| Date | Title | Description |
| 26.08.2026 |
Cramer’s lightning round: Buy QXO | Monday - Friday, 6:00 - 7:00 PM ET
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
BillionToOne: “We decided it’s a pretty dar... |
| 14.05.2026 |
Cramer’s lightning round: Buy BillionToOne | Monday - Friday, 6:00 - 7:00 PM ET
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Silicon Motion Technology: “We like SIMO. I... |
| 12.02.2026 | e2vc Fund III’s EUR 100M to Boost Global Ambition for CEE Startups | e2vc closes its EUR 100M Fund III to support more CEE startup The fund continues its focus on early-stage, globally ambitious founders with strong technical teams The firm deepens global presence, aiding US expansion and bridging internatio... |
| 21.01.2026 | BIOMAKERS Raises Additional $8 Million To Scale Global Precision Oncology Intelligence Platform | BIOMAKERS, a San Francisco-headquartered precision medicine and oncology intelligence company, announced it has closed an additional $8 million in financing as it shifts from building diagnostics and data infrastructure to scaling an AI-nat... |
| 07.11.2025 | Американская биотех-компания BillionToOne выросла до $4,4 млрд после успешного IPO на Nasdaq | Биотехнологическая компания BillionToOne из Менло-Парка (Калифорния), специализирующаяся на молекулярной диагностике, была оценена в $4,4 млрд после того, как её акции подскочили на 66,7% в первый день торгов на Nasdaq. Бумаги компании откр... |
| 06.11.2025 | Американская компания BillionToOne привлекла $273 млн на IPO | - |
| 20.11.2024 | Genetic Testing Delivers Startup Hits And Misses | 3 Shares Email Facebook Twitter LinkedIn
When submitting a genetic test, one usually has a desired outcome in mind. That doesn’t mean the results will bear it out.
Investing in DNA testing startups is much the same. Over the years, startup ... |
| 19.07.2024 | Four U.S.-Based Unicorns Joined The Board In June In The Lowest Monthly Count So Far This Year | 6 Shares Email Facebook Twitter LinkedIn
Four companies joined The Crunchbase Unicorn Board in June 2024, the lowest count so far this year.
The four new additions are U.S.-based and amazingly not tied to the generative sector. Each company... |
| 28.06.2024 | BillionToOne: Molecular Diagnostics Company Raises $130 Million | BillionToOne, a next-generation molecular diagnostics company, announced that it has raised $130 million in an oversubscribed and upsized Series D round. This funding was led by Premji Invest, with significant participation by another incom... |
| 22.06.2024 | BillionToOne's Precision Diagnostics Revolution | In a groundbreaking move that has sent shockwaves through the precision diagnostics industry, BillionToOne, a Menlo Park-based company, recently announced the successful completion of a Series D funding round, raising an impressive $130 mil... |
| 22.06.2024 | BillionToOne Raises $130M in Series D Funding | BillionToOne, a Menlo Park, CA-based precision diagnostics company, raised $130M in Series D funding at an over $1B+ valuation.
The round was led by Premji Invest, with participation by another incoming investor, Neuberger Berman, as well a... |
| 21.06.2024 | BillionToOne raises $130M at $1B-plus valuation | figcaption>span]:font-sans" data-chromatic="ignore">
BillionToOne, a precision diagnostics company, raised a $130 million Series D, valuing it at more than $1 billion, CEO Oguzhan Atay tells Axios exclusively.
Why it ma... |
| 04.04.2024 | Culmination Bio, BillionToOne Partner to Validate Cancer Diagnostics | What You Should Know:
Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful... |
| 04.04.2024 | Culmination Bio and BillionToOne partner to validate cancer diagnostics | BillionToOne will use Culmination Bio data to validate two of its tests
Cancer is on the rise worldwide: according to the World Health Organization, there will be over 35 million new cancer cases in 2050, a 77% increase from the estimated 2... |
| 20.03.2024 | BillionToOne launches BabyPeek add-on to its UNITY prenatal test | BabyPeek is a genetic test that allows parents to discover features and traits as early as 10 weeks
As we move towards more personalized medicine, the importance of precision diagnostics is increasing. Yet, most molecular diagnostics testin... |
| 07.05.2023 | Расцвет FemTech: как технологии меняют сферу женского здоровья | Впервые термин FemTech в 2016 году использовала соосновательница трекера для отслеживания менструального цикла Clu Ила Тин, но в последние пару лет рост в этой области стал очевиден: растут число стартапов и объемы привлеченного инвестирова... |
| 19.12.2022 | BillionToOne Secures Additional $48.5M; Up To $35M Term Loan Facility | BillionToOne laboratory
BillionToOne, Inc., a Menlo Park, CA-based molecular diagnostics company, secured an additional $48.5m of funding, as well as upsized its term loan facility with access to up to $35m.
The $48.5m funding consisted of ... |
| 15.12.2022 | BillionToOne Raises Additional $48.5M |
MENLO PARK, CA, BillionToOne announces it has secured an additional $48.5 million of funding.
>> Click here for more funding data on BillionToOne
>> To export BillionToOne funding data to PDF and Excel, click here
Billion... |
| 31.03.2022 | Precision diagnostics startup BillionToOne raises $125M for the world’s first genetic testing platform that detects disease at the molecular level | Early diagnosis and detection of diseases before they evolve and take up shape is are critical saving millions of lives every year. In recent years, progress has been made in using computers and machine learning to enhance traditional diagn... |
| 31.03.2022 | BillionToOne Raises $125M in Series C Funding | BillionToOne, a Menlo Park, CA-based molecular diagnostics company, raised $125M in Series C funding.
The round was led by Adams Street Partners and Hummingbird Ventures with participation from Baillie Gifford, Neotribe Ventures, Norwest Ve... |
| 30.03.2022 | BillionToOne Raises $125M to Expand Genetic Testing Platform | What You Should Know:
– BillionToOne, a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all raises $125M in Series C funding co-led by Adams Street Partners and exist... |
| 30.03.2022 | BillionToOne Closes $125M Series C Funding |
MENLO PARK, CA, BillionToOne, a next-generation molecular diagnostics company, announces the closure of an oversubscribed Series C funding round of $125 million.
>> Click here for more funding data on BillionToOne
>> To expo... |
| 15.03.2022 | Meet Rebecca Mitchem, Partner at Neotribe Ventures | Mitchem is a co-manager of the recently launched Ignite Fund, which backs growth-stage companies
Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While t... |
| 12.07.2021 | BillionToOne Closes $55M Series B Funding | BillionToOne, Inc., a Menlo Park, Calif.-based molecular diagnostics company, closed a $55m Series B funding round.
The round, announced in June 2021, was led by existing investor Hummingbird Ventures and incoming investor Four Rivers Group... |
| 24.06.2021 | Slone Partners Places Nipun Soni as Chief Financial Officer at BillionToOne | “Nipun is a highly skilled leader and strategic thinker with a successful track record in long-range planning and budgeting, capital raises, and business modeling,” said Slone Partners President Tara Kochis-Stach.
SOUTH RIDING, Va. (PRWEB) ... |
| 20.01.2021 | How to Start a Biotech Company on a Budget | Running a biotech company is capital intensive, and this can make it intimidating to get started. Founders sometimes face a chicken and egg problem: how do you make progress without millions of dollars in funding, and how do you raise milli... |
| 11.03.2020 | BillionToOne Closes $15M Series A+ Funding |
MENLO PARK, CA, BillionToOne has closed its follow-on Series A+ funding round of $15 million.
>> Click here for more funding data on BillionToOne
>> To export BillionToOne funding data to PDF and Excel, click here
Billion... |
| 10.03.2020 | BillionToOne Closes $15M Follow-On Series A+ Funding Round | BillionToOne, Inc., a Menlo Park, Calif.-based precision diagnostics company that invented the patent-pending QCT™ molecular counter platform, closed its follow-on Series A+ funding round of $15m.
The round was led by previous investors Hum... |
| 02.04.2019 | Term Sheet — Tuesday, April 2 | HUNGRY FOR SMALL DEALS
The M&A boom is slowing, and big banks are eyeing smaller deals. Although mega-mergers account for the majority of U.S. deals by dollar value, there’s a larger amount of small deals being closed. And Wall Street i... |
| 01.04.2019 | Daily funding roundup - April 1st, 2019 | Novo raised $4.8M; BillionToOne landed $15M; Academia.edu secured $16M; CollegeVine raised $24
Novo: Novo is a modern banking platform that gives startups and small business owners the technology they need to focus on their businesses. Novo... |
| 01.04.2019 | BillionToOne Announces $15M Series A |
MENLO PARK, CA, BillionToOne has closed its highly oversubscribed Series A funding round of $15 million.
>> Click here for more funding data on BillionToOne
>> To export BillionToOne funding data to PDF and Excel, click here... |
| 31.03.2019 | BillionToOne Raises $15M in Series A Funding | BillionToOne, a Menlo Park, Calif.-based a precision diagnostics company, closed a $15m Series A funding.
The round was led by Hummingbird Ventures and NeoTribe Ventures with participation from Y Combinator, Civilization Ventures, Fifty Yea... |
| 28.03.2019 | Prenatal Testing Firm BillionToOne Closes $15M Series A Financing | From Genome Web –
Read original article |
| 28.03.2019 | Daily funding roundup - March 28th, 2019 | BillionToOne raised $15M; Polyneuron Pharmaceuticals secured $22.6M;Prevail Therapeutics lands $50M
Artiphon: Artiphon is empowering a new generation to explore music-making with smart instruments and adaptive software. Artiphon has raised ... |
| 31.03.2016 | First Fellowship Virtual Demo Day | Congratulations to the Fellowship teams who presented at the first Fellowship Virtual Demo Day!
Find out more about the F2 Fellowship companies here:
Awesound – AdWords for podcasts
BillionToOne – Fetal genetic testing in India
Bulletin... |
| - | BillionToOne | “We are a team at the forefront of disease detection focused on moving Prenatal Screening and Liquid Biopsy forward.” |
